{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:31:22Z","timestamp":1794540682490,"version":"4.9.1"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"ANR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.neuropharm.2022.109379","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:59:11Z","timestamp":1671793151000},"page":"109379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The role of adenosine A2A receptors in Alzheimer's disease and tauopathies"],"prefix":"10.1016","volume":"226","author":[{"given":"Agathe","family":"Launay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouada","family":"Nebie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhenkruthi","family":"Vijaya Shankara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Lebouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Bu\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Faivre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109379_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105253","article-title":"Purinergic signaling orchestrating neuron-glia communication","volume":"162","author":"Agostinho","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2022.109379_bib2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1469-7793.1999.00679.x","article-title":"Adenosinergic modulation of rat basal forebrain neurons during sleep and waking: neuronal recording with microdialysis","volume":"521","author":"Alam","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-3639.2007.00112.x","article-title":"Up\u2010regulation of adenosine receptors in the frontal cortex in Alzheimer's disease","volume":"18","author":"Albasanz","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib4","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1093\/cercor\/bhab188","article-title":"Adenosine A2A receptors contribute to the radial migration of cortical projection neurons through the regulation of neuronal polarization and axon formation","volume":"31","author":"Al\u00e7ada-Morais","year":"2021","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2022.109379_bib5","doi-asserted-by":"crossref","first-page":"C696","DOI":"10.1152\/ajpcell.00202.2002","article-title":"A2B receptor activation promotes glycogen synthesis in astrocytes through modulation of gene expression","volume":"284","author":"Allaman","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/bpa.12592","article-title":"Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology","volume":"28","author":"Alonso-Andr\u00e9s","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib7","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuroscience.2006.07.021","article-title":"Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production","volume":"142","author":"Arendash","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109379_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3233\/JAD-2009-1087","article-title":"Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice","volume":"17","author":"Arendash","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2022.109379_bib9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","article-title":"Tau and tauopathies","volume":"126","author":"Arendt","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2022.109379_bib10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nn.4132","article-title":"Depletion of microglia and inhibition of exosome synthesis halt tau propagation","volume":"18","author":"Asai","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","article-title":"2019 Alzheimer's disease facts and figures","volume":"15","author":"Association","year":"2019","journal-title":"Alzheimer's Dementia"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109379_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.576","article-title":"The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine","volume":"6","author":"Baron","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2022.109379_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0278-6915(95)00093-3","article-title":"Caffeine consumption","volume":"34","author":"Barone","year":"1996","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000014655","article-title":"Adenosine as a biological signal mediating sleepiness following prolonged wakefulness","volume":"9","author":"Basheer","year":"2000","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuropharm.2022.109379_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2012.8","article-title":"Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation","volume":"18","author":"Batalha","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/srep31493","article-title":"The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function","volume":"6","author":"Batalha","year":"2016","journal-title":"Sci. Rep."},{"issue":"6568","key":"10.1016\/j.neuropharm.2022.109379_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1126\/science.abm3902","article-title":"Stabilizing synapses","volume":"374","author":"Blum","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109379_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2009.131","article-title":"Adenosine signaling and function in glial cells","volume":"17","author":"Boison","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neuropharm.2022.109379_bib19","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1017\/S135561771700100X","article-title":"Alzheimer's disease: past, present, and future","volume":"23","author":"Bondi","year":"2017","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuropharm.2022.109379_bib20","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00702-019-01969-2","article-title":"Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment","volume":"126","author":"Borroto-Escuela","year":"2019","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2022.109379_bib22","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1126\/science.284.5422.1982","article-title":"Gating of BDNF-induced synaptic potentiation by cAMP","volume":"284","author":"Boulanger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109379_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0028-3908(00)00117-9","article-title":"Adenosine A1 and A3 receptors mediate inhibition of synaptic transmission in rat cortical neurons","volume":"40","author":"Brand","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib25","first-page":"1","article-title":"Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders","author":"Brandebura","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Translat. Med."},{"issue":"43","key":"10.1016\/j.neuropharm.2022.109379_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4980","article-title":"Microglia become hypofunctional and release metalloproteases and tau seeds when phagocytosing live neurons with P301S tau aggregates","volume":"7","author":"Brelstaff","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neuropharm.2022.109379_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3109\/09637486.2014.940286","article-title":"Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage","volume":"65","author":"Bruce","year":"2014","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","article-title":"Purinergic signalling: from discovery to current developments","volume":"99","author":"Burnstock","year":"2014","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib30","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.neurobiolaging.2008.01.003","article-title":"Modification upon aging of the density of presynaptic modulation systems in the hippocampus","volume":"30","author":"Canas","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"47","key":"10.1016\/j.neuropharm.2022.109379_bib31","doi-asserted-by":"crossref","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","article-title":"Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway","volume":"29","author":"Canas","year":"2009","journal-title":"J. Neurosci."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2022.109379_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuropharm.2013.08.026","article-title":"Predominant loss of glutamatergic terminal markers in a \u03b2-amyloid peptide model of Alzheimer's disease","volume":"76","author":"Canas","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib33","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3233\/JAD-2012-111781","article-title":"High Blood caffeine levels in MCI linked to lack of progression to dementia","volume":"30","author":"Cao","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2022.109379_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570159X13666141210215655","article-title":"Caffeine: cognitive and physical performance enhancer or psychoactive drug?","volume":"13","author":"Cappelletti","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib35","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1093\/brain\/awz288","article-title":"Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor","volume":"142","author":"Carvalho","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2022.109379_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fnins.2018.00520","article-title":"The adenosinergic signaling: a complex but promising therapeutic target for Alzheimer's disease","volume":"12","author":"Cellai","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11064-015-1799-3","article-title":"Adenosine A1 receptor-mediated endocytosis of AMPA receptors contributes to impairments in long-term potentiation (LTP) in the middle-aged rat Hippocampus","volume":"41","author":"Chen","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2022.109379_bib38","first-page":"1","article-title":"The roles of purinergic signaling in psychiatric disorders","volume":"63","author":"Cie\u015blak","year":"2016","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nan.12197","article-title":"Invited review: prion-like transmission and spreading of tau pathology","volume":"41","author":"Clavaguera","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","article-title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","volume":"139","author":"Colin","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1460-9568.2011.07719.x","article-title":"Enhanced role of adenosine A2A receptors in the modulation of LTP in the rat hippocampus upon ageing","volume":"34","author":"Costenla","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11302-013-9364-5","article-title":"A1R\u2013A2AR heteromers coupled to Gs and Gi\/0 proteins modulate GABA transport into astrocytes","volume":"9","author":"Crist\u00f3v\u00e3o-Ferreira","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2022.109379_bib43","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.13724","article-title":"How does adenosine control neuronal dysfunction and neurodegeneration?","volume":"139","author":"Cunha","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.expneurol.2006.08.008","article-title":"Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice","volume":"203","author":"Dall'Igna","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib45","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.bjp.0705185","article-title":"Neuroprotection by caffeine and adenosine A2A receptor blockade of \u03b2-amyloid neurotoxicity","volume":"138","author":"Dall'lgna","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib46","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0006-2952(92)90616-Q","article-title":"Agonist activity of 2-and 5\u2032-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1\u2212 and A2\u2212 adenosine receptors coupled to adenylate cyclase","volume":"43","author":"Daly","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00734999","article-title":"Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines","volume":"3","author":"Daly","year":"1983","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.physbeh.2007.05.031","article-title":"Modulation of glial cell functions by adenosine receptors","volume":"92","author":"Dar\u00e9","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2022.109379_bib49","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1021\/jm4011669","article-title":"Adenosine A2A receptor as a drug discovery target","volume":"57","author":"De Lera Ruiz","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)90373-5","article-title":"Endogenous adenosine modulates long-term potentiation in the hippocampus","volume":"62","author":"De Mendon\u00e7a","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109379_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2015.00409","article-title":"Basal adenosine modulates the functional properties of AMPA receptors in mouse hippocampal neurons through the activation of A1R A2AR and A3R","volume":"9","author":"Di Angelantonio","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib52","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hipo.20894","article-title":"Enhancement of AMPA currents and GluR1 membrane expression through PKA\u2010coupled adenosine A2A receptors","volume":"22","author":"Dias","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2022.109379_bib53","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tins.2012.12.003","article-title":"Adenosine: setting the stage for plasticity","volume":"36","author":"Dias","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib54","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1523\/JNEUROSCI.4454-03.2004","article-title":"Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices","volume":"24","author":"Di\u00f3genes","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hipo.20294","article-title":"Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors","volume":"17","author":"Di\u00f3genes","year":"2007","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2022.109379_bib56","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jnr.20489","article-title":"Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6\u2010hydroxydopamine\u2010lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease","volume":"80","author":"Domenici","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2022.109379_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.neuro.24.1.31","article-title":"The role and regulation of adenosine in the central nervous system","volume":"24","author":"Dunwiddie","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-2009-0920","article-title":"Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study","volume":"16","author":"Eskelinen","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2022.109379_bib59","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-111982","article-title":"Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia","volume":"34","author":"Espinosa","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2022.109379_bib60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnmol.2018.00235","article-title":"Beneficial effect of a selective adenosine A(2A) receptor antagonist in the APPswe\/PS1dE9 mouse model of Alzheimer's disease","volume":"11","author":"Faivre","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib61","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/bph.12970","article-title":"Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission","volume":"172","author":"Ferreira","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/BST20130229","article-title":"From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?","volume":"42","author":"Flaten","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2022.109379_bib63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuropharm.2008.01.011","article-title":"Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine","volume":"54","author":"Fontinha","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib64","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/npp.2009.8","article-title":"Adenosine A2A receptor modulation of hippocampal CA3-CA1 synapse plasticity during associative learning in behaving mice","volume":"34","author":"Fontinha","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib66","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s002100000313","article-title":"Structure and function of adenosine receptors and their genes","volume":"362","author":"Fredholm","year":"2000","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.pharmtox.45.120403.095731","article-title":"CNS: insights from knockouts and drugs","volume":"45","author":"Fredholm","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2022.109379_bib71","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/bph.12234","article-title":"Functional interaction between pre-synaptic \u03b16\u03b22-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum","volume":"169","author":"Gar\u00e7\u00e3o","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib73","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-2010-101428","article-title":"Coffee intake in midlife and risk of dementia and its neuropathologic correlates","volume":"23","author":"Gelber","year":"2011","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.neuropharm.2022.109379_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105363","article-title":"Of adenosine and the blues: the adenosinergic system in the pathophysiology and treatment of major depressive disorder","volume":"163","author":"Gomes","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2022.109379_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/science.abk2055","article-title":"Convergence of adenosine and GABA signaling for synapse stabilization during development","volume":"374","author":"Gomez-Castro","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109379_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104570","article-title":"Synaptic and memory dysfunction in a \u03b2-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine","volume":"132","author":"Gon\u00e7alves","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109379_bib77","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1523\/JNEUROSCI.2834-05.2006","article-title":"Involvement of the CA3\u2013CA1 synapse in the acquisition of associative learning in behaving mice","volume":"26","author":"Gruart","year":"2006","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109379_bib78","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.tins.2021.06.007","article-title":"Cellular senescence at the crossroads of inflammation and Alzheimer's disease","volume":"44","author":"Guerrero","year":"2021","journal-title":"Trends Neurosci."},{"issue":"Suppl. 3","key":"10.1016\/j.neuropharm.2022.109379_bib79","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/S1353-8020(09)70813-2","article-title":"Differential regulation of microglial motility by ATP\/ADP and adenosine","volume":"15","author":"Gyoneva","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2022.109379_bib80","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.cortex.2013.02.009","article-title":"Association of brain-derived neurotrophic factor (BDNF) haploinsufficiency with lower adaptive behaviour and reduced cognitive functioning in WAGR\/11p13 deletion syndrome","volume":"49","author":"Han","year":"2013","journal-title":"Cortex"},{"key":"10.1016\/j.neuropharm.2022.109379_bib81","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00213-004-2104-3","article-title":"Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine","volume":"179","author":"Haskell","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109379_bib82","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/alzrt226","article-title":"Amyloid \u03b2-protein oligomers and Alzheimer's disease","volume":"5","author":"Hayden","year":"2013","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.neuropharm.2022.109379_bib83","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109379_bib84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib85","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.sleh.2014.12.010","article-title":"National Sleep Foundation's sleep time duration recommendations: methodology and results summary","volume":"1","author":"Hirshkowitz","year":"2015","journal-title":"Sleep Health"},{"key":"10.1016\/j.neuropharm.2022.109379_bib87","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1471-4159.2004.02991.x","article-title":"An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats","volume":"92","author":"Hong","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib88","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","article-title":"Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease","volume":"60","author":"Horgusluoglu-Moloch","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2022.109379_bib89","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3390\/antiox9090902","article-title":"Antioxidant and neuroprotective effects of caffeine against Alzheimer's and Parkinson's disease: insight into the role of nrf-2 and A2AR signaling","volume":"9","author":"Ikram","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2022.109379_bib90","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/npp.2016.148","article-title":"Sleep health: reciprocal regulation of sleep and innate immunity","volume":"42","author":"Irwin","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib91","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinte.166.16.1756","article-title":"Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation","volume":"166","author":"Irwin","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.neuropharm.2022.109379_bib92","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2008.05.004","article-title":"Sleep loss activates cellular inflammatory signaling","volume":"64","author":"Irwin","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib93","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbi.2014.09.017","article-title":"Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans","volume":"47","author":"Irwin","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2022.109379_bib94","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109379_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-005-0084-6","article-title":"Effects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation","volume":"182","author":"James","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109379_bib96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1021\/acs.chemrev.6b00119","article-title":"Structurally enabled discovery of adenosine A2A receptor antagonists","volume":"117","author":"Jazayeri","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib97","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/hbm.25121","article-title":"Longitudinal validity of PET-based staging of regional amyloid deposition","volume":"41","author":"Jelistratova","year":"2020","journal-title":"Hum. Brain Mapp."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2022.109379_bib98","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.parkreldis.2020.09.022","article-title":"Can adenosine A(2A) receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?","volume":"80","author":"Jenner","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2022.109379_bib99","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0006-8993(98)00540-X","article-title":"Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist","volume":"800","author":"Jones","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109379_bib100","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109379_bib101","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1159\/000343328","article-title":"A2a adenosine receptor mediates PKA-dependent glutamate release from synaptic-like vesicles and Ca2+ efflux from an IP3-and ryanodine-insensitive intracellular calcium store in astrocytes","volume":"30","author":"Kanno","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib102","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.npp.1300167","article-title":"Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration","volume":"28","author":"Karcz-Kubicha","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ceca.2011.02.009","article-title":"Long-term facilitation of spontaneous calcium oscillations in astrocytes with endogenous adenosine in hippocampal slice cultures","volume":"49","author":"Kawamura","year":"2011","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2022.109379_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114408","article-title":"The P2Y\/P2X divide: how it began","volume":"187","author":"Kennedy","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib105","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1152\/jn.1997.78.4.1965","article-title":"NMDA-Independent LTP by adenosine A2 receptor-mediated postsynaptic AMPA potentiation in hippocampus","volume":"78","author":"Kessey","year":"1997","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib106","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41398-019-0604-5","article-title":"Coffee intake and decreased amyloid pathology in human brain","volume":"9","author":"Kim","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109379_bib107","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2006.03935.x","article-title":"Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease","volume":"98","author":"Kirvell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib108","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/hipo.22655","article-title":"Theta burst stimulation\u2010induced LTP: differences and similarities between the dorsal and ventral CA1 hippocampal synapses","volume":"26","author":"Kouvaros","year":"2016","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2022.109379_bib109","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jnc.14268","article-title":"Adenosine A2A receptors are required for glutamate mG luR5\u2010and dopamine D1 receptor\u2010evoked ERK 1\/2 phosphorylation in rat hippocampus: involvement of NMDA receptor","volume":"145","author":"Krania","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib110","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/mol.58.4.771","article-title":"Adenosine A2A receptors are colocalized with and activate Golf in rat striatum","volume":"58","author":"Kull","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib111","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib112","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.neurobiolaging.2014.03.027","article-title":"Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology","volume":"35","author":"Laurent","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2022.109379_bib113","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib114","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","article-title":"Tau and neuroinflammation: what impact for Alzheimer's disease and tauopathies?","volume":"41","author":"Laurent","year":"2018","journal-title":"Biomed. J."},{"key":"10.1016\/j.neuropharm.2022.109379_bib115","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1523\/JNEUROSCI.6730-10.2011","article-title":"Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens","volume":"31","author":"Lazarus","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib116","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/164_2017_36","article-title":"Adenosine and sleep","volume":"253","author":"Lazarus","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib117","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/WCO.0000000000000502","article-title":"Update on tauopathies","volume":"30","author":"Lebouvier","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib118","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1073\/pnas.061020198","article-title":"Activation of Trk neurotrophin receptors in the absence of neurotrophins","volume":"98","author":"Lee","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109379_bib119","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11302-015-9474-3","article-title":"Adenosine A2B receptor activation stimulates glucose uptake in the mouse forebrain","volume":"11","author":"Lemos","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.neuropharm.2022.109379_bib120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.21315","article-title":"Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces \"off\" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)","volume":"63","author":"LeWitt","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib121","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/S0024-3205(00)01036-5","article-title":"Adenosine enhances glial glutamate efflux via A2a adenosine receptors","volume":"68","author":"Li","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib122","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/mp.2014.182","article-title":"Optogenetic activation of intracellular adenosine A2A receptor signaling in the hippocampus is sufficient to trigger CREB phosphorylation and impair memory","volume":"20","author":"Li","year":"2015","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib123","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1167\/iovs.15-18024","article-title":"The effect of A2A receptor antagonist on microglial activation in experimental glaucoma","volume":"57","author":"Liu","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib124","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.77.5.2551","article-title":"Subclasses of external adenosine receptors","volume":"77","author":"Londos","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109379_bib125","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1152\/jn.1999.82.6.3196","article-title":"Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats","volume":"82","author":"Lopes","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib126","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bcp.2019.06.008","article-title":"The physiological effects of caffeine on synaptic transmission and plasticity in the mouse hippocampus selectively depend on adenosine A1 and A2A receptors","volume":"166","author":"Lopes","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114367","article-title":"Use of knockout mice to explore CNS effects of adenosine","volume":"187","author":"Lopes","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3389\/fphar.2018.00526","article-title":"Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression","volume":"9","author":"L\u00f3pez-Cruz","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib129","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.neuropharm.2010.01.008","article-title":"Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum","volume":"58","author":"Lovinger","year":"2010","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109379_bib130","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.3390\/molecules27123737","article-title":"Neuroprotective effect of caffeine in Alzheimer's disease","volume":"27","author":"M Yelanchezian","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2022.109379_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1113\/jphysiol.1986.sp015923","article-title":"Adenosine agonists reduce voltage\u2010dependent calcium conductance of mouse sensory neurones in cell culture","volume":"370","author":"MacDonald","year":"1986","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109379_bib132","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1038\/s41380-021-01075-4","article-title":"Habitual coffee drinkers display a distinct pattern of brain functional connectivity","volume":"26","author":"Magalh\u00e3es","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib133","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2009.07.016","article-title":"LTP impairment by fractalkine\/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R)","volume":"215","author":"Maggi","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib134","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1468-1331.2002.00421.x","article-title":"Does caffeine intake protect from Alzheimer's disease?","volume":"9","author":"Maia","year":"2002","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109379_bib135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1471-4159.2010.07101.x","article-title":"Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission","volume":"116","author":"Martire","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib136","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/glia.22290","article-title":"Adenosine A2A receptors modulate glutamate uptake in cultured astrocytes and gliosomes","volume":"60","author":"Matos","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2022.109379_bib137","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1523\/JNEUROSCI.1828-13.2013","article-title":"Antagonistic interaction between adenosine A2A receptors and Na+\/K+-ATPase-\u03b12 controlling glutamate uptake in astrocytes","volume":"33","author":"Matos","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib138","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopsych.2015.02.026","article-title":"Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia","volume":"78","author":"Matos","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib139","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/brain\/awp076","article-title":"Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia","volume":"132","author":"Melani","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2022.109379_bib140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuropharm.2013.03.023","article-title":"Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of \u03b17, but not \u03b14\u03b22* nicotinic acetylcholine receptor binding in the brain","volume":"71","author":"Metaxas","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib141","doi-asserted-by":"crossref","first-page":"R1715","DOI":"10.1152\/ajpregu.00247.2005","article-title":"Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats","volume":"289","author":"Methippara","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib142","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1111\/bph.14497","article-title":"Adenosine A(2A) receptors facilitate synaptic NMDA currents in CA1 pyramidal neurons","volume":"175","author":"Mouro","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib143","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.bbamem.2010.12.017","article-title":"Recent developments in adenosine receptor ligands and their potential as novel drugs","volume":"1808","author":"M\u00fcller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2022.109379_bib144","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/practneurol-2015-001162","article-title":"Effects of coffee\/caffeine on brain health and disease: what should I tell my patients?","volume":"16","author":"Nehlig","year":"2016","journal-title":"Practical Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","article-title":"Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects","volume":"17","author":"Nehlig","year":"1992","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib146","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0968-0004(84)90176-2","article-title":"Adenosine and the concept of \u201cretaliatory metabolites","volume":"9","author":"Newby","year":"1984","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib147","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.neuropharm.2022.109379_bib148","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10100","article-title":"A new neuromodulatory pathway with a glial contribution mediated via A2a adenosine receptors","volume":"39","author":"Nishizaki","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2022.109379_bib149","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamaneurol.2014.1173","article-title":"Effect of 1 night of total sleep deprivation on cerebrospinal fluid \u03b2-amyloid 42 in healthy middle-aged men: a randomized clinical trial","volume":"71","author":"Ooms","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib150","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.3930","article-title":"Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory","volume":"18","author":"Orr","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2017.10.014","article-title":"Istradefylline reduces memory deficits in aging mice with amyloid pathology","volume":"110","author":"Orr","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016088","article-title":"Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists","volume":"6","author":"Orru","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109379_bib153","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1038\/ncomms3909","article-title":"Adenosine is required for sustained inflammasome activation via the A2A receptor and the HIF-1\u03b1 pathway","volume":"4","author":"Ouyang","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2022.109379_bib154","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1111\/bph.13180","article-title":"Adenosine A2A receptors are necessary and sufficient to trigger memory impairment in adult mice","volume":"172","author":"Pagnussat","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149371","article-title":"Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription","volume":"132","author":"Paiva","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109379_bib156","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/glia.23969","article-title":"Purinergic signaling in peripheral nervous system glial cells","volume":"69","author":"Patritti-Cram","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2022.109379_bib157","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.nlm.2004.12.002","article-title":"Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat","volume":"83","author":"Pereira","year":"2005","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib158","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0306-4522(00)00220-7","article-title":"Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study","volume":"99","author":"Porkka-Heiskanen","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109379_bib159","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1152\/jn.00896.2002","article-title":"Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats","volume":"90","author":"Rebola","year":"2003","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib160","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109379_bib161","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuron.2007.11.023","article-title":"Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses","volume":"57","author":"Rebola","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109379_bib162","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07178.x","article-title":"Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction","volume":"117","author":"Rebola","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib163","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4103\/1673-5374.182683","article-title":"Adenosine A2A receptors in neuronal outgrowth: a target for nerve regeneration?","volume":"11","author":"Ribeiro","year":"2016","journal-title":"Neural regeneration research"},{"key":"10.1016\/j.neuropharm.2022.109379_bib164","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0301-0082(02)00155-7","article-title":"Adenosine receptors in the nervous system: pathophysiological implications","volume":"68","author":"Ribeiro","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib165","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/stem.3421","article-title":"Regulation of hippocampal postnatal and adult neurogenesis by adenosine A2A receptor: interaction with brain-derived neurotrophic factor","volume":"39","author":"Ribeiro","year":"2021","journal-title":"Stem Cell."},{"issue":"10","key":"10.1016\/j.neuropharm.2022.109379_bib166","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neurobiolaging.2007.03.025","article-title":"Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats","volume":"29","author":"Rodrigues","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2022.109379_bib167","doi-asserted-by":"crossref","first-page":"12117","DOI":"10.1523\/JNEUROSCI.2146-16.2016","article-title":"Adenosine kinase deficiency in the brain results in maladaptive synaptic plasticity","volume":"36","author":"Sandau","year":"2016","journal-title":"J. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2022.109379_bib168","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.3233\/JAD-2010-091387","article-title":"Caffeine intake and dementia: systematic review and meta-analysis","volume":"20","author":"Santos","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2022.109379_bib169","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/jnc.13291","article-title":"Adenosine A2A receptors permit mG luR5\u2010evoked tyrosine phosphorylation of NR 2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation","volume":"135","author":"Sarantis","year":"2015","journal-title":"J. Neurochem."},{"issue":"9","key":"10.1016\/j.neuropharm.2022.109379_bib170","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer's disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2022.109379_bib171","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/jm9911480","article-title":"Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A(2A)-selective adenosine receptor antagonists","volume":"43","author":"Sauer","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib172","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1471-4159.2005.03395.x","article-title":"Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia","volume":"95","author":"Saura","year":"2005","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109379_bib173","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14789450.5.2.207","article-title":"Biochemistry of Tau in Alzheimer's disease and related neurological disorders","volume":"5","author":"Sergeant","year":"2008","journal-title":"Expet Rev. Proteonomics"},{"issue":"197","key":"10.1016\/j.neuropharm.2022.109379_bib174","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006258","article-title":"Adenosine receptor antagonist including caffeine alter fetal brain development in mice","volume":"5","author":"Silva","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109379_bib175","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2018.05.024","article-title":"Blockade of adenosine A2A receptors recovers early deficits of memory and plasticity in the triple transgenic mouse model of Alzheimer's disease","volume":"117","author":"Silva","year":"2018","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-017-0489-6","article-title":"Atypical, non-standard functions of the microtubule associated Tau protein","volume":"5","author":"Sotiropoulos","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109379_bib177","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","article-title":"The intersection of amyloid beta and tau at synapses in Alzheimer's disease","volume":"82","author":"Spires-Jones","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109379_bib178","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuropharm.2015.11.018","article-title":"Protein phosphatase role in adenosine A1 receptor-induced AMPA receptor trafficking and rat hippocampal neuronal damage in hypoxia\/reperfusion injury","volume":"102","author":"Stockwell","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109379_bib179","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0166-4328(00)00258-8","article-title":"Adenosinergic modulation of basal forebrain and preoptic\/anterior hypothalamic neuronal activity in the control of behavioral state","volume":"115","author":"Strecker","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109379_bib180","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1471-4159.2005.03455.x","article-title":"Adenosine A2A receptors and metabotropic glutamate 5 receptors are co\u2010localized and functionally interact in the hippocampus: a possible key mechanism in the modulation of N\u2010methyl\u2010D\u2010aspartate effects","volume":"95","author":"Tebano","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib181","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2007.05046.x","article-title":"Adenosine A2A receptors are required for normal BDNF levels and BDNF\u2010induced potentiation of synaptic transmission in the mouse hippocampus","volume":"104","author":"Tebano","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib182","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41380-018-0110-9","article-title":"Age-related shift in LTD is dependent on neuronal adenosine A2A receptors interplay with mGluR5 and NMDA receptors","volume":"25","author":"Temido-Ferreira","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib183","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/156802610791268756","article-title":"Adenosine receptors: what we know and what we are learning","volume":"10","author":"Trincavelli","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2022.109379_bib184","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1073\/pnas.82.14.4857","article-title":"Adenosine-activated potassium conductance in cultured striatal neurons","volume":"82","author":"Trussell","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuropharm.2022.109379_bib185","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00053-5","article-title":"Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase","volume":"34","author":"Ueland","year":"1982","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib186","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smrv.2017.07.005","article-title":"Sleep and Alzheimer's disease: a pivotal role for the suprachiasmatic nucleus","volume":"40","author":"Van Erum","year":"2018","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neuropharm.2022.109379_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11915","article-title":"Early synaptic deficits in the APP\/PS1 mouse model of Alzheimer's disease involve neuronal adenosine A2A receptors","volume":"7","author":"Viana da Silva","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109379_bib188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0754-y","article-title":"Intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.neuropharm.2022.109379_bib189","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1073858413518152","article-title":"NREM and REM sleep: complementary roles in recovery after wakefulness","volume":"20","author":"Vyazovskiy","year":"2014","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2022.109379_bib190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109379_bib191","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.biopsych.2013.05.003","article-title":"Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain","volume":"75","author":"Wei","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109379_bib192","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.neuropharm.2004.01.008","article-title":"Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons","volume":"46","author":"Wirkner","year":"2004","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109379_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000161","article-title":"Physiology and effects of nucleosides in mice lacking all four adenosine receptors","volume":"17","author":"Xiao","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib194","article-title":"Adenosine A2A receptors control synaptic remodeling in the adult brain","volume":"12","author":"Xu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109379_bib195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jcp.20138","article-title":"Animal models for the study of adenosine receptor function","volume":"202","author":"Yaar","year":"2005","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109379_bib196","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"48","key":"10.1016\/j.neuropharm.2022.109379_bib197","doi-asserted-by":"crossref","first-page":"15100","DOI":"10.1523\/JNEUROSCI.4215-09.2009","article-title":"Genetic deletion of A2A adenosine receptors in the striatum selectively impairs habit formation","volume":"29","author":"Yu","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib198","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29055","article-title":"Striatal adenosine A(2A) receptor neurons control active-period sleep via parvalbumin neurons in external globus pallidus","volume":"6","author":"Yuan","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2022.109379_bib199","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Zetterberg","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109379_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.98","article-title":"Adenosine A2A receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation","volume":"7","author":"Zhao","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109379_bib201","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/ijbs.34211","article-title":"Caffeine inhibits NLRP3 inflammasome activation by suppressing MAPK\/NF-\u03baB and A2aR signaling in LPS-induced THP-1 macrophages","volume":"15","author":"Zhao","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109379_bib202","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1021\/acschemneuro.2c00167","article-title":"Rapid eye movement sleep deprivation enhances adenosine receptor activation and the CREB1\/YAP1\/c-myc Axis to alleviate depressive-like behaviors in rats","volume":"13","author":"Zhao","year":"2022","journal-title":"ACS Chem. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822004385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:20:47Z","timestamp":1758439247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822004385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":202,"alternative-id":["S0028390822004385"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109379","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of adenosine A2A receptors in Alzheimer's disease and tauopathies","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109379"}}